The most efficient services.
The most qualified professionals.
Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA consultants and industry experts has offered compliance, regulatory affairs, and science & technology services to clients around the world.
Learn More About UsStay in the know
Sign up today for the Lachman Consultants blog.
Get the latest news on industry compliance, regulatory affairs, technical services, and a whole lot more.
ADVANCE. CONFIDENTLY.
As long-standing leaders in technical and regulatory consulting services, Lachman Consultants provides both experience and excellence through an unmatched team of respected industry professionals and SMEs.
PHARMACEUTICAL
Lachman Consultants has an unsurpassed reputation for excellence in technical, regulatory consultation, and guidance services for the Pharmaceutical Industry, including generic and novel drug products, OTC, and monograph drugs, and many more.
MEDICAL DEVICE/COMBINATION PRODUCTS
Lachman Consultants’ comprehensive list of services extends to all classes of medical devices and combination products including In Vitro Diagnostics, Integral, Cross-labeled and Kitted Combination Products.
BIOLOGICS
Lachman Consultants has a reputation for demonstrated excellence in technical, regulatory consulting, and guidance services for biologics, including cell and gene therapy, human cell and tissue products, monoclonal antibodies, biosimilars and many more.
REGULATORY AFFAIRS
Lachman Consultants’ Regulatory Affairs group is comprised of former senior-level FDA managers, FDA reviewers, and industry experts. Their goal is simple; provide simple workable solutions for client’s regulatory problems or issues at the highest levels of efficiency and excellence.
Mock FDA Audits
Are you fully prepared for an inspection at your facility?
Our team of experienced ex-FDA investigators offer comprehensive Mock FDA Audit services to help you prepare for an actual FDA inspection. Our team of experts will conduct a thorough inspection of your facility, review your documentation, and provide you with valuable feedback on areas that need improvement to ensure compliance with FDA regulations – both remotely and on-site.
Learn More About Mock FDA Audits
The Lachman Consultants Blog
The latest on industry compliance, regulatory affairs, technical services, and a whole lot more.
FY2027 Animal Drug User Fees Announced
FDA Announces Biosimilar User Fee Rates for FY 2027
503B Outsourcing Facility Fee Rates for FY 2027
PDUFA User Fees Announced for 2027 – Surprise! Surprise!
FDA Announces Over-the-Counter Drug Monograph User Fees for FY 2027
